GlassScriptPhysician profile
Catherine Artoun
NPI 1841552502
$1,769.37
in general payments reported to CMS, 2019-2025
19 companies · $32.28 in 2025
The $32.28 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $405 · 2021: $133 · 2022: $306 · 2023: $115 · 2024: $32.59 · 2025: $32.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $180.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $575.59 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Therapeuticsmd, INC. | $211.56 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $142.00 | 2019-2023 | |
| Organon LLC | $118.23 | 2022 | |
| Allergan, INC. | $107.61 | 2019-2020 | |
| Hologic Sales and Service, LLC | $91.26 | 2019-2025 | Aptima |
| Merck Sharp & Dohme LLC | $84.97 | 2019 | |
| Minerva Surgical, INC | $54.69 | 2019 | |
| Avion Pharmaceuticals | $53.56 | 2020-2021 | |
| Pfizer INC. | $52.58 | 2019-2022 | |
| Daiichi Sankyo INC. | $49.67 | 2019-2020 | |
| Lupin INC. | $46.10 | 2019-2020 | |
| Exeltis, USA INC. | $41.40 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $40.06 | 2019-2020 | |
| Astellas Pharma US INC | $32.59 | 2024 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $19.56 | 2023 | Myfembree |
| Aspira Women'S Health INC | $18.49 | 2019 | |
| Mayne Pharma Commercial LLC | $18.15 | 2019 | |
| Duchesnay USA Incorporated | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Artoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.